| | | | |

Immune System Changes Could Signal Mesothelioma Risk

The state of an asbestos-exposed person’s immune system might give doctors clues about how likely they are to develop malignant mesothelioma.

It’s a fear for any person who has worked around asbestos – that one day they may develop the asbestos-linked cancer, mesothelioma. Pleural mesothelioma can take decades to develop, causes few symptoms at first, and is extremely hard to treat. Right now, there is no definitive way to screen for it. Even making a mesothelioma diagnosis is a challenge.

Now, a team of occupational medicine experts in Japan and China have released an article in Environmental Health and Preventive Medicine detailing a list of biomarkers they believe may indicate asbestos-induced immune changes that could result in mesothelioma.

How Asbestos Causes Malignant Mesothelioma

When shards of asbestos dust are inhaled, they tend to stay in the lungs, working their way deep into the tissues and into the pleural lining that surrounds the lungs.

Over time, the chronic inflammation caused by this foreign substance in the tissue appears to trigger DNA changes that can lead to malignant mesothelioma.

But before that happens, the conditions for the development of cancer have to be just right, including alterations in the immune system.

A healthy immune system is continually rooting out potentially cancerous cells and destroying them. But the Japanese and Chinese scientists say asbestos can change the situation in definable, measurable ways, making it more feasible to assess mesothelioma risk.

Immune System Cells and Mesothelioma Development

According to the new research, asbestos has an has an immunological effect on a number of different lymphocytes including T cells (Treg), responder CD4+ T helper cells (Tresp), CD8+ cytotoxic T lymphocytes (CTL), and natural killer (NK) cells.

“Results show that asbestos exposure impairs antitumor immunity through enhancement of regulatory T cell function and volume, reduction of CXCR3 chemokine receptor in responder CD4+ T helper cells, and impairment of the killing activities of CD8+ cytotoxic T lymphocytes (CTL) and NK cells,” writes lead author Hidenori Matsuzaki with Japan’s Kawasaki Medical School.

The researchers say there are other unexplored molecules that can be found in the blood that may also be helpful in assessing malignant mesothelioma risk, but they say the cells they have laid out in their new report are a good place to start.

“Biomarkers based on immunological alterations may be helpful in clinical situations to screen the high-risk population exposed to asbestos and susceptible to asbestos-related cancers such as mesothelioma,” concludes the report.

Other Biomarkers for Mesothelioma

Although there is no definitive screening test for mesothelioma or mesothelioma risk, previous studies have identified a number of proteins in the blood that may indicate the early stages of the disease.

The most well-known of these is the MESOMARK test for Soluble Mesothelin-Related Peptides (SMRP). The manufacturer of the test says that SMRP can be elevated years before an actual mesothelioma diagnosis is made.

Other possible mesothelioma biomarkers include the protein fibulin-3, plasma osteopontin, and the ratio of neutrophils to lymphocytes in the blood.

Because there is no way to know who will develop this rare cancer, it is important for people who have worked around asbestos to communicate this to their doctor, know the symptoms, and have regular physical exams to monitor their health.

Source:

Matsuzaki, H, et al, “Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos”, December 2017, Environmental Health and Preventive Medicine

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…